Berenberg Bank Boosts Diploma (LON:DPLM) Price Target to GBX 4,700

Diploma (LON:DPLM - Free Report) had its price objective lifted by Berenberg Bank from GBX 4,400 ($55.26) to GBX 4,700 ($59.03) in a research note released on Monday morning, MarketBeat Ratings reports. The brokerage currently has a buy rating on the stock.

Several other brokerages have also issued reports on DPLM. Deutsche Bank Aktiengesellschaft reissued a buy rating and issued a GBX 4,500 ($56.52) price target on shares of Diploma in a research note on Tuesday, May 7th. Shore Capital reissued a buy rating on shares of Diploma in a research note on Monday. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average price target of GBX 3,787.50 ($47.57).

Diploma Trading Up 0.6 %

Shares of DPLM stock traded up GBX 26 ($0.33) during mid-day trading on Monday, hitting GBX 4,086 ($51.32). The company's stock had a trading volume of 382,375 shares, compared to its average volume of 271,489. Diploma has a 52 week low of GBX 2,772.88 ($34.83) and a 52 week high of GBX 4,340 ($54.51). The company has a debt-to-equity ratio of 44.05, a quick ratio of 0.80 and a current ratio of 2.06. The company's fifty day simple moving average is GBX 3,589.52 and its 200-day simple moving average is GBX 3,417.33. The company has a market cap of £5.48 billion, a PE ratio of 4,490.11, a P/E/G ratio of 2.82 and a beta of 0.73.

Diploma Cuts Dividend

The firm also recently declared a dividend, which will be paid on Friday, June 7th. Investors of record on Thursday, May 23rd will be given a GBX 17.30 ($0.22) dividend. This represents a yield of 0.44%. The ex-dividend date is Thursday, May 23rd. Diploma's payout ratio is currently 6,263.74%.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.